Neil James Clendeninn, SVP & Chief Medical Officer at Heron Therapeutics, holds 0.00 shares in Heron Therapeutics (Ticker: HRTX), holds 19.92K shares in Achieve Life Sciences (Ticker: ACHV). Most recently, Neil James Clendeninn ― shares of Heron Therapeutics on ― for an estimated value of ―.